Exploring how Leishmania amazonensis exploits host cholesterol and the therapeutic potential of targeting this dependency for treating leishmaniasis.
Discover how elevated Apolipoprotein B levels in tuberculosis patients reveal the bacterium's strategy of hijacking cholesterol metabolism for survival.